FDA Inspection
DIAGASTDIAGAST – FDA Inspection, Apr 19, 2024
Record Details
This FDA Inspection record concerns DIAGAST, with an inspection on April 19, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d15ba283-2382-4e2b-ba78-de05c6b00630
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1236304
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
6- 21 CFR 803.50(a)(2)Individual Report of Malfunction
- 21 CFR 600.14(a)(1)Who must report - manufacturer
- 21 CFR 820.80(c)Documentation
- 21 CFR 820.150Lack of or inadequate procedures for storage.
- 21 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
- 21 CFR 803.17(b)(1)Info evaluated to determine if event was reportable
Full citation text and observation details available on the Dashboard.
Other FDA inspections of DIAGAST
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2019 | Not classified | Office of Inspections and Investigations | |
| February 21, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 17, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 8, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 16, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for DIAGAST
- FDA Inspection 1087957 - 2019-03-21
- FDA Inspection 1012901 - 2017-02-21
- FDA Inspection 927715 - 2015-03-17
- FDA Inspection 715544 - 2011-03-08
- FDA Inspection 594229 - 2009-01-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.